NCT05613959View on ClinicalTrials.gov

Evaluating the Novel Veress Plus Needle

CompletedOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

September 26, 2021

Study Completion Date

September 26, 2021

Conditions
Pneumoperitoneum
Interventions
DEVICE

Veress +

The Veress+ safety mechanism was used

DEVICE

Conventional Veress

The Conventional Veress Needle was used

Trial Locations (1)

MSD 2080

Laboratory for Anatomy, Valletta

All Listed Sponsors
lead

Prof Jean Calleja-Agius

OTHER

NCT05613959 - Evaluating the Novel Veress Plus Needle | Biotech Hunter | Biotech Hunter